EXEL - Exelixis, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	Own	H
8/12/26 19:34	8/10/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Beckerle Mary C	CA	D		3	S.d	-1,933	45.85	-42	21	D
6/3/26 18:52	6/1/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Wyszomierski Jack L	CA	D		3	S.d	-4,905	44.18	-111	359	D
6/3/26 18:51	6/1/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Eckhardt Sue Gail	CA	D		3	S	-1,466	45.10	-33	21	D
5/28/26 18:25	5/26/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Aftab Dana	CA	O	EVP,Rese	4	S	-7,701	45.40	-170	671	D
5/22/26 17:01	5/20/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Haley Patrick J.	CA	O	EVP,Comm	3	S.m	-7,597	44.13	-172	382	D
5/19/26 18:58	5/18/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Senner Christopher J.	CA	O	EVP,CFO	2	S.m	-4,556	45.65	-100	979	D
5/19/26 18:58	5/18/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Hefti Brenda	CA	O	SVP,GC	2	S	-1,154	45.63	-25	112	D
5/8/26 19:03	5/7/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Freire Maria C	CA	D		1	S.d	-949	46.00	-21	101	D
5/8/26 19:03	5/7/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Poste George	CA	D		1	S	-2,743	45.71	-60	119	D
2/19/26 19:18	2/17/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Smith Julie	CA	D		1	S.dm	-4,687	44.00	-107	21	D
2/18/26 20:48	2/13/26	EXEL	Health	BioPrd	Biological Products, (No Diag	Oliver Bob	CA	D		1	S.d	-1,325	43.81	-30	21	D
11/13/25 19:12	11/12/25	EXEL	Health	BioPrd	Biological Products, (No Diag	Papadopoulos Stelios	CA	D		1	S	-4,355	43.55	-100	1,189	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person